Merck KGaA (MRK) Rating Reiterated by JPMorgan Chase & Co.
Merck KGaA (FRA:MRK)‘s stock had its “neutral” rating restated by stock analysts at JPMorgan Chase & Co. in a note issued to investors on Friday.
Other equities analysts have also issued research reports about the stock. Bankhaus Lampe set a €102.00 ($113.33) target price on shares of Merck KGaA and gave the company a “buy” rating in a report on Friday, June 17th. Berenberg Bank set a €101.00 ($112.22) target price on shares of Merck KGaA and gave the company a “buy” rating in a report on Friday, July 22nd. equinet AG set a €85.00 ($94.44) target price on shares of Merck KGaA and gave the company a “buy” rating in a report on Monday, July 18th. DZ Bank AG restated a “buy” rating on shares of Merck KGaA in a report on Thursday, July 14th. Finally, Deutsche Bank AG set a €110.00 ($122.22) target price on shares of Merck KGaA and gave the company a “buy” rating in a report on Thursday, July 28th. One research analyst has rated the stock with a sell rating, twelve have given a hold rating and ten have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of €100.82 ($112.03).
Merck KGaA (FRA:MRK) traded up 2.848% during trading on Friday, hitting €97.898. The company had a trading volume of 425 shares. Merck KGaA has a 12 month low of €70.87 and a 12 month high of €100.00. The company’s 50 day moving average price is €95.74 and its 200-day moving average price is €89.91. The company has a market cap of €42.56 billion and a PE ratio of 30.631.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/14/merck-kgaa-mrk-rating-reiterated-by-jpmorgan-chase-co.html
Merck KGaA Company Profile
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.